Leepeptin
| Internal ID | 9fc8c9a0-ae3b-43d5-b7ec-d49b6eca31dd |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | (4S)-5-[[(3S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-carboxy-2-hydroxypropyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-[[(2S,5S,11S,14S,17S,20S,23S)-17-(2-amino-2-oxoethyl)-14-(3-carbamimidamidopropyl)-20-(carboxymethyl)-5-[(4-hydroxyphenyl)methyl]-2-(2-methylpropyl)-3,6,9,12,15,18,21,26-octaoxo-11-propan-2-yl-1,4,7,10,13,16,19,22-octazacyclohexacosane-23-carbonyl]amino]-5-oxopentanoic acid |
| SMILES (Canonical) | CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CN=CN3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC(=O)O)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C8CCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N8)CC(=O)O)CC(=O)N)CCCNC(=N)N)C(C)C)CC9=CC=C(C=C9)O)CC(C)C |
| SMILES (Isomeric) | CC[C@H](C)C(C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N[C@@H](CC6=CNC7=CC=CC=C76)C(=O)NC([C@@H](C)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]8CCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8)CC(=O)O)CC(=O)N)CCCNC(=N)N)C(C)C)CC9=CC=C(C=C9)O)CC(C)C |
| InChI | InChI=1S/C110H143N27O31/c1-8-55(6)91(136-96(154)71(33-35-87(145)146)122-95(153)70-32-34-85(143)121-72(37-53(2)3)97(155)125-73(39-58-24-28-63(139)29-25-58)93(151)119-51-86(144)135-90(54(4)5)107(165)124-69(23-16-36-116-110(113)114)94(152)131-79(44-83(111)141)102(160)133-81(46-88(147)148)104(162)123-70)108(166)134-80(45-84(112)142)103(161)128-76(41-60-48-117-67-21-14-12-19-65(60)67)100(158)130-78(43-62-50-115-52-120-62)101(159)126-74(38-57-17-10-9-11-18-57)99(157)132-82(47-89(149)150)105(163)127-75(40-59-26-30-64(140)31-27-59)98(156)129-77(106(164)137-92(56(7)138)109(167)168)42-61-49-118-68-22-15-13-20-66(61)68/h9-15,17-22,24-31,48-50,52-56,69-82,90-92,117-118,138-140H,8,16,23,32-47,51H2,1-7H3,(H2,111,141)(H2,112,142)(H,115,120)(H,119,151)(H,121,143)(H,122,153)(H,123,162)(H,124,165)(H,125,155)(H,126,159)(H,127,163)(H,128,161)(H,129,156)(H,130,158)(H,131,152)(H,132,157)(H,133,160)(H,134,166)(H,135,144)(H,136,154)(H,137,164)(H,145,146)(H,147,148)(H,149,150)(H,167,168)(H4,113,114,116)/t55-,56+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,90-,91?,92?/m0/s1 |
| InChI Key | UDBDQVQDKZANRU-GYZZVETDSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C110H143N27O31 |
| Molecular Weight | 2339.50 g/mol |
| Exact Mass | 2339.0476857 g/mol |
| Topological Polar Surface Area (TPSA) | 942.00 Ų |
| XlogP | -1.30 |
| RefChem:152702 |
| (4S)-4-((((2S,5S,11S,14S,17S,20S,23S)-14-(3-carbamimidamidopropyl)-20-(carboxymethyl)-3,6,9,12,15,18,21,26-octahydroxy-17-((C-hydroxycarbonimidoyl)methyl)-5-((4-hydroxyphenyl)methyl)-2-(2-methylpropyl)-11-(propan-2-yl)-1,4,7,10,13,16,19,22-octaazacyclohexacosa-1(26),3,6,9,12,15,18,21-octaen-23-yl)(hydroxy)methylidene)amino)-4-(((2S)-1-(((1S)-1-(((1S)-1-(((1S)-1-(((1S)-1-(((1S)-2-carboxy-1-(((1S)-1-(((1S)-1-(((2R)-1-carboxy-2-hydroxypropyl)-C-hydroxycarbonimidoyl)-2-(1H-indol-3-yl)ethyl)-C-hydroxycarbonimidoyl)-2-(4-hydroxyphenyl)ethyl)-C-hydroxycarbonimidoyl)ethyl)-C-hydroxycarbonimidoyl)-2-phenylethyl)-C-hydroxycarbonimidoyl)-2-(1H-imidazol-5-yl)ethyl)-C-hydroxycarbonimidoyl)-2-(1H-indol-3-yl)ethyl)-C-hydroxycarbonimidoyl)-2-(C-hydroxycarbonimidoyl)ethyl)-C-hydroxycarbonimidoyl)-2-methylbutyl)-C-hydroxycarbonimidoyl)butanoate |
| (4S)-4-((((2S,5S,11S,14S,17S,20S,23S)-14-(3-carbamimidamidopropyl)-20-(carboxymethyl)-3,6,9,12,15,18,21,26-octahydroxy-17-(2-hydroxy-2-iminoethyl)-5-((4-hydroxyphenyl)methyl)-2-(2-methylpropyl)-11-propan-2-yl-1,4,7,10,13,16,19,22-octazacyclohexacosa-3,6,9,12,15,18,21,26-octaen-23-yl)-hydroxymethylidene)amino)-5-((3S)-1-((2S)-1-((2S)-1-((2S)-1-((2S)-1-((2S)-3-carboxy-1-((2S)-1-((2S)-1-((2R)-1-carboxy-2-hydroxypropyl)imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)imino-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl)imino-1-hydroxypropan-2-yl)imino-1-hydroxy-3-phenylpropan-2-yl)imino-1-hydroxy-3-(1H-imidazol-5-yl)propan-2-yl)imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)imino-1,4-dihydroxy-4-iminobutan-2-yl)imino-1-hydroxy-3-methylpentan-2-yl)imino-5-hydroxypentanoic acid |
| (4S)-4-({[(2S,5S,11S,14S,17S,20S,23S)-14-(3-carbamimidamidopropyl)-20-(carboxymethyl)-3,6,9,12,15,18,21,26-octahydroxy-17-[(C-hydroxycarbonimidoyl)methyl]-5-[(4-hydroxyphenyl)methyl]-2-(2-methylpropyl)-11-(propan-2-yl)-1,4,7,10,13,16,19,22-octaazacyclohexacosa-1(26),3,6,9,12,15,18,21-octaen-23-yl](hydroxy)methylidene}amino)-4-{[(2S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-2-carboxy-1-{[(1S)-1-{[(1S)-1-{[(2R)-1-carboxy-2-hydroxypropyl]-C-hydroxycarbonimidoyl}-2-(1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}-2-(4-hydroxyphenyl)ethyl]-C-hydroxycarbonimidoyl}ethyl]-C-hydroxycarbonimidoyl}-2-phenylethyl]-C-hydroxycarbonimidoyl}-2-(1H-imidazol-5-yl)ethyl]-C-hydroxycarbonimidoyl}-2-(1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}-2-(C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}-2-methylbutyl]-C-hydroxycarbonimidoyl}butanoate |
| (4S)-4-[[[(2S,5S,11S,14S,17S,20S,23S)-14-(3-carbamimidamidopropyl)-20-(carboxymethyl)-3,6,9,12,15,18,21,26-octahydroxy-17-(2-hydroxy-2-iminoethyl)-5-[(4-hydroxyphenyl)methyl]-2-(2-methylpropyl)-11-propan-2-yl-1,4,7,10,13,16,19,22-octazacyclohexacosa-3,6,9,12,15,18,21,26-octaen-23-yl]-hydroxymethylidene]amino]-5-[(3S)-1-[(2S)-1-[(2S)-1-[(2S)-1-[(2S)-1-[(2S)-3-carboxy-1-[(2S)-1-[(2S)-1-[(2R)-1-carboxy-2-hydroxypropyl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]imino-1-hydroxypropan-2-yl]imino-1-hydroxy-3-phenylpropan-2-yl]imino-1-hydroxy-3-(1H-imidazol-5-yl)propan-2-yl]imino-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]imino-1,4-dihydroxy-4-iminobutan-2-yl]imino-1-hydroxy-3-methylpentan-2-yl]imino-5-hydroxypentanoic acid |
| (4S)-5-(((3S)-1-(((2S)-4-amino-1-(((2S)-1-(((2S)-1-(((2S)-1-(((2S)-3-carboxy-1-(((2S)-1-(((2S)-1-(((2R)-1-carboxy-2-hydroxypropyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-1,4-dioxobutan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-4-(((2S,5S,11S,14S,17S,20S,23S)-17-(2-amino-2-oxoethyl)-14-(3-carbamimidamidopropyl)-20-(carboxymethyl)-5-((4-hydroxyphenyl)methyl)-2-(2-methylpropyl)-3,6,9,12,15,18,21,26-octaoxo-11-propan-2-yl-1,4,7,10,13,16,19,22-octazacyclohexacosane-23-carbonyl)amino)-5-oxopentanoic acid |
| (4S)-5-[[(3S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-carboxy-2-hydroxypropyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-[[(2S,5S,11S,14S,17S,20S,23S)-17-(2-amino-2-oxoethyl)-14-(3-carbamimidamidopropyl)-20-(carboxymethyl)-5-[(4-hydroxyphenyl)methyl]-2-(2-methylpropyl)-3,6,9,12,15,18,21,26-octaoxo-11-propan-2-yl-1,4,7,10,13,16,19,22-octazacyclohexacosane-23-carbonyl]amino]-5-oxopentanoic acid |
| CHEBI:212260 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| No predicted properties yet! | |||
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.99% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.92% | 83.82% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.76% | 97.64% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.72% | 96.09% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.61% | 97.23% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 99.52% | 90.24% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.31% | 91.11% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 99.26% | 90.08% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 99.04% | 88.56% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 99.01% | 90.20% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 98.80% | 91.81% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.57% | 98.94% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 98.30% | 94.75% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 97.88% | 91.71% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 97.50% | 88.10% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 97.43% | 96.90% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 97.07% | 88.42% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 96.81% | 95.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 96.80% | 96.67% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.73% | 100.00% |
| CHEMBL4071 | P08311 | Cathepsin G | 96.40% | 94.64% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.40% | 99.17% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.06% | 95.56% |
| CHEMBL2535 | P11166 | Glucose transporter | 95.80% | 98.75% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 95.47% | 85.00% |
| CHEMBL3837 | P07711 | Cathepsin L | 94.90% | 96.61% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 94.70% | 94.45% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 94.66% | 98.33% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 94.63% | 82.38% |
| CHEMBL4801 | P29466 | Caspase-1 | 94.57% | 96.85% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 94.01% | 98.59% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 93.98% | 95.38% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 93.95% | 96.11% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 93.54% | 96.67% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 93.52% | 90.17% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.37% | 97.09% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 93.35% | 93.10% |
| CHEMBL2821 | P00748 | Coagulation factor XII | 93.28% | 96.21% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 93.00% | 90.65% |
| CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 92.62% | 99.09% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 91.93% | 98.05% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.90% | 95.89% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 91.80% | 83.10% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 91.09% | 99.23% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 91.00% | 95.52% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 90.54% | 97.14% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 89.56% | 98.89% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 89.44% | 92.32% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 89.29% | 100.00% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 89.22% | 95.89% |
| CHEMBL2093869 | P05106 | Integrin alpha-IIb/beta-3 | 88.91% | 95.42% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.82% | 100.00% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 87.87% | 96.33% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 87.80% | 95.56% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 87.67% | 95.50% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 87.46% | 94.66% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 87.10% | 100.00% |
| CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 86.59% | 94.62% |
| CHEMBL1781 | P11387 | DNA topoisomerase I | 86.35% | 97.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 86.32% | 93.00% |
| CHEMBL4461 | Q9NTG7 | NAD-dependent deacetylase sirtuin 3 | 86.31% | 94.36% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 86.24% | 96.28% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 86.19% | 95.50% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 86.14% | 96.25% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 86.12% | 92.97% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 85.54% | 99.15% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 85.20% | 94.45% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 84.67% | 82.50% |
| CHEMBL4447 | Q9Y337 | Kallikrein 5 | 83.79% | 87.50% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 83.66% | 98.24% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 83.35% | 97.43% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 83.25% | 82.86% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 83.21% | 85.31% |
| CHEMBL4302 | P08183 | P-glycoprotein 1 | 82.60% | 92.98% |
| CHEMBL2095172 | P14867 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 81.52% | 92.67% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 80.85% | 94.00% |
| CHEMBL1949 | P62937 | Cyclophilin A | 80.38% | 98.57% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146683593 |
| LOTUS | LTS0077282 |
| wikiData | Q105270287 |